# Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.

> **NCT04399525** · NA · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 12 (actual)

## Conditions studied

- Pruritus

## Interventions

- **DRUG:** Desloratadine Single Dose
- **DRUG:** Levocetirizine Single Dose
- **DRUG:** Desloratadine Fourfold Dose
- **DRUG:** Levocetirizine Fourfold Dose

## Key facts

- **NCT ID:** NCT04399525
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-28
- **Primary completion:** 2020-03-12
- **Final completion:** 2020-03-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399525, "Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04399525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*